Choueiri TK - Search Results

1

Epigenomic charting and functional annotation of risk loci in renal cell carcinoma.

Nassar AH, Abou Alaiwi S, Baca SC, Adib E, Corona RI, Seo JH, Fonseca MAS, Spisak S, El Zarif T, Tisza V, Braun DA, Du H, He M, Flaifel A, Alchoueiry M, Denize T, Matar SG, Acosta A, Shukla S, Hou Y, Steinharter J, Bouchard G, Berchuck JE, O'Connor E, Bell C, Nuzzo PV, Mary Lee GS, Signoretti S, Hirsch MS, Pomerantz M, Henske E, Gusev A, Lawrenson K, Choueiri TK, Kwiatkowski DJ, Freedman ML. Nassar AH, et al. Among authors: choueiri tk. Nat Commun. 2023 Jan 21;14(1):346. doi: 10.1038/s41467-023-35833-5. Nat Commun. 2023. PMID: 36681680 Free PMC article.

2

An association between renal cell carcinoma and multiple myeloma: a case series and clinical implications.

Choueiri TK, Baz RC, McFadden CM, Khasawneh M, Karam MA, Kelly M, Hussein MA. Choueiri TK, et al. BJU Int. 2008 Mar;101(6):712-5. doi: 10.1111/j.1464-410X.2007.07268.x. Epub 2007 Oct 26. BJU Int. 2008. PMID: 17970789

3

Efficacy of sunitinib and sorafenib in metastatic papillary and chromophobe renal cell carcinoma.

Choueiri TK, Plantade A, Elson P, Negrier S, Ravaud A, Oudard S, Zhou M, Rini BI, Bukowski RM, Escudier B. Choueiri TK, et al. J Clin Oncol. 2008 Jan 1;26(1):127-31. doi: 10.1200/JCO.2007.13.3223. J Clin Oncol. 2008. PMID: 18165647

4

Time to prostate-specific antigen nadir independently predicts overall survival in patients who have metastatic hormone-sensitive prostate cancer treated with androgen-deprivation therapy.

Choueiri TK, Xie W, D'Amico AV, Ross RW, Hu JC, Pomerantz M, Regan MM, Taplin ME, Kantoff PW, Sartor O, Oh WK. Choueiri TK, et al. Cancer. 2009 Mar 1;115(5):981-7. doi: 10.1002/cncr.24064. Cancer. 2009. PMID: 19152438 Free PMC article.

5

Treatment selection for patients with metastatic renal cell carcinoma.

Atkins MB, Choueiri TK, Cho D, Regan M, Signoretti S. Atkins MB, et al. Among authors: choueiri tk. Cancer. 2009 May 15;115(10 Suppl):2327-33. doi: 10.1002/cncr.24231. Cancer. 2009. PMID: 19402069 Free PMC article. Review.

6

Risk of bilateral renal cell cancer.

Wiklund F, Tretli S, Choueiri TK, Signoretti S, Fall K, Adami HO. Wiklund F, et al. Among authors: choueiri tk. J Clin Oncol. 2009 Aug 10;27(23):3737-41. doi: 10.1200/JCO.2008.20.6524. Epub 2009 Jul 13. J Clin Oncol. 2009. PMID: 19597028

7

A case of adult metastatic Xp11 translocation renal cell carcinoma treated successfully with sunitinib.

Choueiri TK, Mosquera JM, Hirsch MS. Choueiri TK, et al. Clin Genitourin Cancer. 2009 Oct;7(3):E93-4. doi: 10.3816/CGC.2009.n.031. Clin Genitourin Cancer. 2009. PMID: 19815489

8

Targeted therapies: sunitinib in RCC-expanded access equals expanded benefit?

Choueiri TK, Atkins MB. Choueiri TK, et al. Nat Rev Clin Oncol. 2009 Dec;6(12):679-80. doi: 10.1038/nrclinonc.2009.170. Nat Rev Clin Oncol. 2009. PMID: 19942921

9

Carbonic anhydrase IX and pathological features as predictors of outcome in patients with metastatic clear-cell renal cell carcinoma receiving vascular endothelial growth factor-targeted therapy.

Choueiri TK, Regan MM, Rosenberg JE, Oh WK, Clement J, Amato AM, McDermott D, Cho DC, Atkins MB, Signoretti S. Choueiri TK, et al. BJU Int. 2010 Sep;106(6):772-8. doi: 10.1111/j.1464-410X.2010.09218.x. Epub 2010 Mar 2. BJU Int. 2010. PMID: 20230385

10

Vascular endothelial growth factor-targeted therapy for the treatment of adult metastatic Xp11.2 translocation renal cell carcinoma.

Choueiri TK, Lim ZD, Hirsch MS, Tamboli P, Jonasch E, McDermott DF, Dal Cin P, Corn P, Vaishampayan U, Heng DY, Tannir NM. Choueiri TK, et al. Cancer. 2010 Nov 15;116(22):5219-25. doi: 10.1002/cncr.25512. Cancer. 2010. PMID: 20665500 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

781 results

Search Page